Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis
Alexey Surov, Maciej Pech, Daniel Geßner, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 10, pp. 5298-5310
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Nascent to novel methods to evaluate malnutrition and frailty in the surgical patient
Carla M. Prado, Katherine L. Ford, Marı́a Cristina González, et al.
Journal of Parenteral and Enteral Nutrition (2022) Vol. 47, Iss. S1
Open Access | Times Cited: 61
Prevalence of sarcopenia in patients with solid tumors: A meta‐analysis based on 81,814 patients
Alexey Surov, Andreas Wienke
Journal of Parenteral and Enteral Nutrition (2022) Vol. 46, Iss. 8, pp. 1761-1768
Open Access | Times Cited: 59
Effects of β‐hydroxy β‐methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review
Carla M. Prado, Camila E. Orsso, Suzette L. Pereira, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1623-1641
Open Access | Times Cited: 52
Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges
Urvi A. Shah, Tarah J. Ballinger, Rusha Bhandari, et al.
JNCI Monographs (2023) Vol. 2023, Iss. 61, pp. 56-67
Open Access | Times Cited: 19
The role of myokines in cancer: crosstalk between skeletal muscle and tumor
Se-Young Park, Byeong-Oh Hwang, Na‐Young Song
BMB Reports (2023) Vol. 56, Iss. 7, pp. 365-373
Open Access | Times Cited: 19
Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial)
Cristina García García, Isabel M. Vegas‐Aguilar, Rosalía Rioja-Vázquez, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 522-522
Open Access | Times Cited: 18
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
Maximilian Thormann, Mattes Hinnerichs, Felix Barajas Ordonez, et al.
Academic Radiology (2022) Vol. 30, Iss. 8, pp. 1552-1561
Open Access | Times Cited: 25
The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes
Robert A. Hiatt, Margaret F. Clayton, Karen Collins, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 8, pp. 886-895
Open Access | Times Cited: 16
Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis
Alexey Surov, Alexandra Strobel, Jan Borggrefe, et al.
European Radiology (2023) Vol. 33, Iss. 9, pp. 6426-6437
Closed Access | Times Cited: 14
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
Alexey Surov, Andreas Wienke, Jan Borggrefe, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 8, pp. 1016-1027
Open Access | Times Cited: 6
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)
Maurizio Muscaritoli, Gil Bar‐Sela, Nicolò Matteo Luca Battisti, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 380-380
Open Access | Times Cited: 11
Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition
Sarah A. Purcell, Dieuwertje E. Kok, Tyler G. Ketterl, et al.
JNCI Monographs (2023) Vol. 2023, Iss. 61, pp. 3-11
Open Access | Times Cited: 10
A Scoping Review of the Implications and Applications of Body Composition Assessment in Locally Advanced and Locally Recurrent Rectal Cancer
Dinh Van, Ioanna Drami, Edward T. Pring, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 846-846
Open Access
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer
Mitchell S. von Itzstein, Sawsan Rashdan, Suzanne E. Dahlberg, et al.
The Oncologist (2025) Vol. 30, Iss. 3
Open Access
Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial
Alexey Surov, Maximilian Thormann, Andreas Wienke, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience
Nadiye Sever, Emil Yunusov, Eşber Çağlar, et al.
Nutrition and Cancer (2025), pp. 1-9
Closed Access
Exchange of Quantitative Computed Tomography Assessed Body Composition Data Using Fast Healthcare Interoperability Resources as a Necessary Step Toward Interoperable Integration of Opportunistic Screening Into Clinical Practice: Methodological Development Study
Yutong Wen, Vin Yeang Choo, Jan Horst Eil, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e68750-e68750
Open Access
Digestive toxicity in cancer treatments. Bibliographic review. Influence on nutritional status
Teresa Alonso Domínguez, Miguel Civera Andrés, José Antonio Santiago Crespo, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2023) Vol. 70, Iss. 2, pp. 136-150
Closed Access | Times Cited: 7
Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis
Alexey Surov, Hans‐Jonas Meyer, Andreas Wienke
Oncology (2022) Vol. 100, Iss. 9, pp. 498-504
Open Access | Times Cited: 11
CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas
Alexey Surov, Hans‐Jonas Meyer, Mattes Hinnerichs, et al.
European Radiology (2023) Vol. 34, Iss. 2, pp. 790-796
Closed Access | Times Cited: 6
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
Anouk W. M. A. Schaeffers, Lot A. Devriese, Carla H. van Gils, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294147-e0294147
Open Access | Times Cited: 6
Nutritional Status Indicators Predict Tolerability to Adjuvant Chemotherapy in Patients with Stage II/III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Shinya Abe, Hiroaki Nozawa, Kazuhito Sasaki, et al.
Digestion (2024) Vol. 105, Iss. 5, pp. 345-358
Open Access | Times Cited: 2
The Prevalence of Sarcopenia in Patients with Solid Tumors Differs Across Regions: A Systematic Review
Maximilian Thormann, Hans‐Jonas Meyer, Andreas Wienke, et al.
Nutrition and Cancer (2024), pp. 1-13
Closed Access | Times Cited: 2
Value of sarcopenia in the resection of colorectal liver metastases—a systematic review and meta-analysis
D. Wagner, Valerie Wienerroither, M Scherrer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis
Hans‐Jonas Meyer, Alexandra Strobel, Andreas Wienke, et al.
Clinical Colorectal Cancer (2022) Vol. 21, Iss. 3, pp. e213-e225
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top